National Institutes of Health: Hepatitis trials

The registry lists 115 Hepatitis studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 40 have results posted.

Phase 1 15Phase 2 48Phase 3 15Phase 4 8No phase 37(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Risk of Post Transfusion Hepatitis C Virus InfectionCompletedNCT00005339
• Natural History of Post-transfusion Non-A, Non-B HepatitisCompletedNCT00005306
• A Controlled Prospective Study of Transfusion-Associated HepatitisCompletedNCT00004848
• Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
• History of Hepatitis C in Volunteer Blood DonorsCompletedNCT00001982
• Collections of Blood and Stool Samples in Patients With Acute HepatitisCompletedNCT00001879
• Long-Term Therapy With Ribavirin for Chronic Hepatitis CCompletedNCT00001854Phase 4
• Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
• Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanCompletedNCT00001712
• Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2
• A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C InfectionCompletedNCT00001117
• The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNCT00001035Phase 1
• The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUCompletedNCT00000654Phase 2
• Hepatitis B Vaccine Clinical TrialCompletedNCT00000583Phase 3
• Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3